The medical polyether ether ketone market generated $582.4 million in 2021, and it is expected to rise to $1,146.6 million in 2030, advancing at a rate of 7.8% from 2021 to 2030, ascribed to the massive replacement of the metallic implants made from PEEK, due to increasing government funding to healthcare services and the emergence of private players.
Moreover, high-performance plastic garners have a high preference among materials for trauma fixation, dental implants, cardiovascular devices, and numerous other applications. In addition, the rise in the geriatric population in Asian, North American, and European countries, along with rising sports injuries are expected to boost the market.
The rapid industrialization, and increase in the research activities in the developing countries, more preferably in the APAC region boost the medical polyether ether ketone market, due to an increase in the manufacturing of PEEK-based medical products. In addition, the major players in the market are focusing on a range of strategic plans for business development, such as investments, partnerships, and product launches to advance their position in the market. Thus, it has resulted in high-grade polymers for devices & medical implants.
North America contributes significant revenue to the medical PEEK market, ascribed to the expansion of healthcare facilities, and innovations in medical devices. Moreover, the surging requirement for stents, heart valves, spine implants, and knee and hip implants led by the growing population in the country, results in an increase in medical-grade plastics usage.
Moreover, the penetration of the medical devices and component manufacturers that utilize PEEK in the country boosts the market. Along with this, the presence of major manufacturing companies in the U.S. drives the region’s market.
Therefore, the increasing use of PEEK as titanium substituent in dental implants and prevalence of the cardiac diseases propel the market.
